Jiří Minařík (Jiri Minarik)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 19

Top Venues

International journal of molecular sciences

Cancers

European journal of haematology

Biomedicines

This page only lists publications with an associated author ORCID identifier.

Publications

Monika Vlachová, Jana Gregorová, Petra Vychytilova-Faltejskova, Natalia Anna Gabło, Lenka Radová, Lenka Pospíšilová, Martina Almáši, Martin Stork, Zdeňka Knechtová, Jiří Minařík, Tereza Popková, Tomas Jelinek, Roman Hájek, Luděk Pour, Lucie Říhová, Sabina Sevcikova
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma. International journal of molecular sciences 23 (23) (2022)
Monika Vlachová, Jana Gregorová, Petra Vychytilova-Faltejskova, Natalia Anna Gabło, Lenka Radová, Lenka Pospíšilová, Martina Almáši, Martin Stork, Zdeňka Knechtová, Jiří Minařík, Tereza Popková, Tomas Jelinek, Roman Hájek, Luděk Pour, Lucie Říhová, Sabina Sevcikova
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma. International journal of molecular sciences 23 (23) (2022)
Monika Vlachová, Jana Gregorová, Petra Vychytilova-Faltejskova, Natalia Anna Gabło, Lenka Radová, Lenka Pospíšilová, Martina Almáši, Martin Stork, Zdeňka Knechtová, Jiří Minařík, Tereza Popková, Tomas Jelinek, Roman Hájek, Luděk Pour, Lucie Říhová, Sabina Sevcikova
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma. International journal of molecular sciences 23 (23) (2022)
Petra Hübnerová, Marta Karhanová, Petra Krhovska, Jiří Minařík, Petr Mlčák, Barbora Pašková, Zuzana Schreiberová, Irena Šínová, Jana Zapletalová, Martin Sin
Retinal oxygen saturation in monoclonal gammopathies patients: A pilot study. Acta ophthalmologica (2022)
Monika Vlachová, Jana Gregorová, Petra Vychytilova-Faltejskova, Natalia Anna Gabło, Lenka Radová, Lenka Pospíšilová, Martina Almáši, Martin Stork, Zdeňka Knechtová, Jiří Minařík, Tereza Popková, Tomas Jelinek, Roman Hájek, Luděk Pour, Lucie Říhová, Sabina Sevcikova
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma. International journal of molecular sciences 23 (23) (2022)
Jiří Minařík, Sabina Sevcikova
Immunomodulatory Agents for Multiple Myeloma. Cancers 14 (23) (2022)
Jiří Minařík, Sabina Sevcikova
Immunomodulatory Agents for Multiple Myeloma. Cancers 14 (23) (2022)
Martin Stork, Sabina Sevcikova, Tomas Jelinek, Jiří Minařík, Jakub Radocha, Tomas Pika, Lenka Pospisilova, Ivan Spicka, Jan Straub, Petr Pavlicek, Alexandra Jungova, Zdenka Knechtova, Viera Sandecka, Vladimir Maisnar, Roman Hajek, Ludek Pour
Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas. Biomedicines 10 (10) (2022)
Monika Vlachová, Jana Gregorová, Petra Vychytilova-Faltejskova, Natalia Anna Gabło, Lenka Radová, Lenka Pospíšilová, Martina Almáši, Martin Stork, Zdeňka Knechtová, Jiří Minařík, Tereza Popková, Tomas Jelinek, Roman Hájek, Luděk Pour, Lucie Říhová, Sabina Sevcikova
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma. International journal of molecular sciences 23 (23) (2022)
Jiří Minařík, Sabina Sevcikova
Immunomodulatory Agents for Multiple Myeloma. Cancers 14 (23) (2022)
Jiří Minařík, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Tomas Pika, Ludek Pour, Petr Pavlicek, Lubica Harvanova, Lenka Pospisilova, Petra Krhovska, Denisa Novakova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Jaroslav Bacovsky, Vladimir Maisnar, Roman Hajek
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy. Cancers 14 (20) (2022)
Viera Sandecká, Luděk Pour, Ivan Špička, Jiří Minařík, Jakub Radocha, Tomáš Jelínek, Adriana Heindorfer, Petr Pavlíček, Michal Sýkora, Alexandra Jungová, Petr Kessler, Marek Wróbel, David Starostka, Jana Ullrychová, Lukáš Stejskal, Martin Stork, Jan Straub, Tomáš Pika, Lucie Brožová, Sabina Sevcikova, Vladimír Maisnar, Roman Hájek
Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data. European journal of haematology 107 (4) (2021)
Martina Zátopková, Tereza Ševčíková, Viola Fanfani, Zuzana Chyra, Lucie Říhová, Renata Bezdekova, David Zihala, Kateřina Growková, Jana Filipova, Lucie Černá, Lucie Broskevičová, Fedor Kryukov, Jiří Minařík, Jana Smejkalová, Vladimir Maisnar, Lubica Harvanová, Ludek Pour, Alexandra Jungova, Tereza Popkova, Juli Rodriguez Bago, Anjana Anilkumar Sithara, Matous Hrdinka, Tomas Jelinek, Michal Simicek, Giovanni Stracquadanio, Roman Hajek
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine. Blood advances (2021)
Jiří Minařík, Tomas Pika, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Ludek Pour, Petr Pavlicek, Martin Mistrik, Lucie Brozova, Petra Krhovska, Katerina Machalkova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Jaroslav Bacovsky, Lenka Capkova, Michal Sykora, Petr Kessler, Lukas Stejskal, Adriana Heindorfer, Jana Ullrychova, Tomas Skacel, Vladimir Maisnar, Roman Hajek
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice. BMC cancer 21 (1) (2021)
Jiří Minařík, Tomas Szotkowski, Jan Hrbek, Petra Krhovska, Eva Buriankova, Jitka Proskova, Tomas Pika, Jaroslav Bacovsky
A rare case of bifocal, extramedullary and hyposecretory relapse of multiple myeloma. Clinical case reports 9 (8) (2021)
Jakub Radocha, Tomas Jelinek, Ludek Pour, Ivan Spicka, Jiří Minařík, Tereza Popkova, Alexandra Jungova, Petr Pavlicek, Lucie Brozova, Martin Stork, Frantisek Sedlak, Petra Krhovska, Vladimir Maisnar, Adriana Heindorfer, Michal Sykora, Marek Wrobel, Peter Mikula, Petr Kessler, Jana Ullrychova, Roman Hajek
Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation. International journal of laboratory hematology 43 (5) (2021)
Anna Petrackova, Jiří Minařík, Lenka Sedlarikova, Tereza Libigerova, Alzbeta Hamplova, Petra Krhovska, Jana Balcarkova, Tomas Pika, Tomas Papajik, Eva Kriegova
Diagnostic deep-targeted next-generation sequencing assessment of TP53 gene mutations in multiple myeloma from the whole bone marrow. British journal of haematology 189 (4) (2020)
Evangelos Terpos, Karthik Ramasamy, Nadjoua Maouche, Jiří Minařík, Ioannis Ntanasis-Stathopoulos, Eirini Katodritou, Matthew W Jenner, Hana Plonkova, Maria Gavriatopoulou, Grant D Vallance, Tomas Pika, Maria Kotsopoulou, Jaimal Kothari, Tomas Jelinek, Efstathios Kastritis, Robin Aitchison, Meletios- Athanasios Dimopoulos, Athanasios Zomas, Roman Hájek
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma. Annals of hematology 99 (5) (2020)
Jiří Minařík, Martin Novak, Patrik Flodr, Jana Balcarkova, Miroslava Mlynarcikova, Petra Krhovska, Tomas Pika, Zuzana Pikalova, Jaroslav Bacovsky, Vlastimil Scudla
CD38-negative relapse in multiple myeloma after daratumumab-based chemotherapy. European journal of haematology 99 (2) (2017)

Jiří Minařík.css-eqlu8i{font-size:small;padding-left:4px;} (Jiri Minarik)

Publication Activity (10 Years)

Top Topics

Top Venues

Jiří Minařík (Jiri Minarik)